10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒     Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended June 30, 2019

-OR-

☐    Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from _________ to________

Commission File # 000-27251

24/7 Kid Doc, Inc.

 (Exact name of registrant as specified in its charter)

Florida	59-3564984
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification #)

8269 Burgos Ct., Orlando, FL	32836
(Address of principal executive offices)	(Zip Code)

(828) 244-5980

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  [ ]   No [x ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes [ ]     No [x ]

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a Non-accelerated Filer, or a small reporting company as defined by Rule 12b-2 of the Exchange Act):

Large accelerated filer        [  ]	Non-accelerated Filer             [  ]
Accelerated filer                 [  ]	Smaller reporting company   ☒
	Emerging growth company   ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes-  ☐      No [X]

The number of outstanding shares of the registrant's common stock as of August 13, 2019:   Common Stock –50,964,655

1

24/7 KID DOC, INC.

FORM 10-Q

For the quarterly period ended June 30, 2019

INDEX

PART I – FINANCIAL INFORMATION

	Page
Item 1.  Financial Statements (Unaudited)	3
Item 2.  Management's Discussion and Analysis of   Financial Condition and Results of Operations	9
Item 3.  Quantitative and Qualitative Disclosures   About Market Risk	10
Item 4.  Controls and Procedures	10

PART II – OTHER INFORMATION

Item 1.  Legal Proceedings	12
Item 1A.  Risk Factors	12
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds	12
Item 3.  Defaults upon Senior Securities	12
Item 4.  Mine Safety Disclosures	12
Item 5.  Other Information	12
Item 6.  Exhibits	12
SIGNATURES	13

2

24/7 Kid Doc, Inc.

Balance Sheets

	June 30, 2019	December 31, 2018
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$49,658	$76,286
Cash in attorney trust accounts	-	11,834
Total current assets	49,658	88,120
Property and equipment, at cost, net	759	902
Total Assets	$50,417	$89,022
LIABILITIES AND STOCKHOLDERS’ EQUITY         (DEFICIT)
Current liabilities:
Accrued expenses	$8,000	$17,500
Advance from shareholder	19,443	-
Notes payable	255,833	117,199
Total current liabilities	283,276	134,699
Stockholders' equity (deficit):
Preferred stock, $0.0001 par value, 5,000,000 shares    authorized, 1,000,000 and 1,000,000 issued and outstanding	100	100
Common stock, $0.0001 par value, 200,000,000 shares    authorized, 51,810,502 and 51,810,502 issued and    50,964,655 and 50,392,855 shares outstanding	5,181	5,181
Additional paid-in capital	8,451,308	8,451,308
Treasury stock, 1,417,647 and 795,347 shares, at cost	(60,395)	(40,773)
Accumulated (deficit)	(8,629,053)	(8,461,493)
Total Stockholders’ deficit	(232,859)	(45,677)
Total Liabilities and Stockholders’ deficit	$50,417	$89,022

See accompanying notes to financial statements

3

24/7 Kid Doc, Inc.

Statements of Operations

For the Three Months and Six Months Ended June 30, 2019 and 2018

(Unaudited)

	Three Months		Six Months
	2019	2018	2019	2018
Sales	$-	$-	$-	$-
Cost of sales and services	-	-	-	-
Gross profit	-	-	-	-
General and administrative expenses	81,575	7,694	153,934	13,259
Income (loss) from operations	(81,575)	(7,694)	(153,934)	(13,259)
Other income (expense):
Other income	-	-	-	1,404
Interest expense	(7,212)	(374)	(13,626)	(748)
Total other income (expense), net	(7,212)	(374)	(13,626)	656
Net income (loss)	$(88,787)	$(8,068)	$(167,560)	$(12,603)
Per share information:
Basic and diluted income (loss) per share	$(0.00)	$(0.00)	$(0.00)	$(0.00)
Weighted average shares outstanding
Preferred	1,000,000	-	1,000,000	-
Common	50,455,513	50,810,502	50,668,979	50,810,502

See accompanying notes to financial statements

4

24/7 Kid Doc, Inc.

Statement of Stockholders’ Equity (Deficit)

For the Six Months Ended June 30, 2019 and 2018

	Preferred Shares	Common Shares	Preferred Stock Amount	Common Stock Amount	Additional Paid-in Capital	Treasury Shares	Stock Amount	Accumulated (Deficit)	Total
Balance December 31, 2017	-	51,810,502	$ -	$ 5,181	$ 8,332,805	671,650	$ (39,009)	$ (8,400,130)	$ (101,253)
Subscribed stock					$ 5,000				5,000
Net loss for the six months ended June 30, 2018	-	-	-	-	-	-	-	(12,603)	(12,603)
Balance June 30, 2018	-	51,810,502	-	$ 5,181	$ 8,337,805	671,650	(39,009)	(8,412,733)	(108,656)
Balance December 31, 2018	1,000,000	51,810,502	$ 100	$ 5,181	$ 8,451,308	795,347	$ (40,773)	$ (8,461,493)	$ (45,677)
Treasury stock purchased						622,300	(19,622)		(19,622)
Net loss for the six months ended June 30, 2019	-	-	-	-	-	-	-	(167,560)	(167,560)
Balance June 30, 2019	1,000,000	51,810,502	$ 100	$ 5,181	$ 8,451,308	1,417,647	(60,395)	(8,629,053)	(232,859)

See accompanying notes to unaudited financial statements.

5

24/7 Kid Doc, Inc.

Statements of Cash Flows

For the Six Months Ended June 30, 2019 and 2018

(Unaudited)

	2019	2018
Cash flows from operating activities
Net income (loss)	$(167,560)	$(12,604)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	143	144
Interest added to shareholder loans	-	748
Interest added to notes payable	13,626	-
Change in assets and liabilities:
Decrease in cash in attorney’s trust account	11,834	-
Decrease in accounts payable and accrued expenses	(9,500)	-
Total adjustments	16,103	892
Net cash (used in) operating activities	$(151,457)	$(11,712)
Cash provided by financing activities:
Proceeds from notes payable	125,008	-
Proceeds from shareholder advance	19,443	-
Proceeds from subscribed shares	-	5,000
Purchase of treasury stock	(19,622)	-
	124,829	5,000
Increase (decrease) in cash and cash equivalents	(26,628)	(6,712)
Cash and cash equivalents, beginning of period	76,286	10,139
Cash and cash equivalents, end of period	$49,658	$3,427
Supplemental cash flow information:
Cash paid for interest	$-	$-
Cash paid for income taxes	$-	$-

See accompanying notes to unaudited financial statements.

6

24/7 KID DOC, INC.

NOTES TO FINANCIAL STATEMENTS

JUNE 30, 2019

(UNAUDITED)

(1)Basis of Presentation and Going Concern 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and Rule 8.03 of Regulation SX.   As such, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (including normal, recurring adjustments) considered necessary for a fair presentation have been included.

The business plan is to create a company that will deliver pediatric services to children and adults 24 hours a day, 7 days a week here in the United States.  In addition, we will be looking to provide these same services via the Internet to people throughout the world, especially in places where it is difficult to have available pediatric doctors or the standard of care is a concern.  While we do not anticipate having significant cash outlays until we implement our business plan, there can be no assurance that such model will result in profitable operations, and/or that we will be able to obtain the debt or equity financing necessary to pay our expenses.  Either of these factors could result in us having difficulty continuing as a going concern.    The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities should we be unable to continue as a going concern.  

The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year.  For further information, refer to the financial statements of the Company as of and for the years ended December 31, 2018 and 2017, including notes, filed with the Company’s Form 10-12G.

(2)Recent Accounting Pronouncements 

The Financial Accounting Standards Board issued a new accounting standard on accounting for leases which went into effect at the end of 2018.  We have not entered into any lease arrangements and therefore this new accounting standard has no effect on our financial statements.

There are no other new accounting pronouncements for which adoption is expected to have a material effect on our financial statements in future accounting periods.

7

(3)Basic and Diluted Income (Loss) Per Share 

The Company calculates basic and diluted income (loss) per share as required by the FASB Accounting Standards Codification. Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods when we report a net loss, anti-dilutive common stock equivalents are not considered in the computation.  We did not have any dilutive common stock equivalents during any of the six-month periods ended June 30, 2019 and 2018.

8

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Trends and Uncertainties.  There are no other known trends, events or uncertainties that have, or are reasonably likely to have, a material impact on our short term or long-term liquidity.  Sources of liquidity will come from sales of our services.  There are no material commitments for capital expenditure currently.  There are no trends, events or uncertainties that have had or are reasonably expected to have a material impact on the net sales or revenues or income from continuing operations There are no other known causes for any material changes from period to period in one or more-line items of our financial statements.

Our common stock is traded on the OTC QB market under the trading symbol TVMD.

Capital Resources and Source of Liquidity.  

For the six months ended June 30, 2019, we had a net loss of $167,560.  We had the following adjustments to reconcile net loss to net cash used in operating activities: we recorded depreciation adjustments of $143 and had interest added to notes payable of $13,626.  We had a decrease in cash in attorney’s trust account of $11,834 and a decrease in accounts payable and accrued expenses of $9,500.  We had net cash used in operating activities of $151,457 for the six months ended June 30, 2019.

For the six months ended June 30, 2018, we had a net loss of $12,604.  We had the following adjustments to reconcile net loss to net cash used in operating activities: we recorded depreciation adjustments of $144 and had interest added to shareholder loans of $748.  As a result, we had net cash used in operating activities of $11,712 for the six months ended June 30, 2018.

For the six months ended June 30, 2019, we received $125,008 as proceeds from notes payable.  We received $19,443 as proceeds from a shareholder advance.  We spent $19,622 for the purchase of treasury stock.  As a result, we had net cash provided by financing activities of $124,829 for the six months ended June 30, 2019.  For the six months ended June 30, 2018, we received $5,000 from a subscription to purchase common shares.

We did not pursue any investing activities for the six months ended June 30, 2019 and 2018.

While we believe that our cash on hand will be sufficient to conduct operations through December 31, 2019, we recognize that our ability to continue as a going concern is dependent on our ability to generate profitable operations and no assurance can be given that we will be able to accomplish such endeavor.   

Results of Operations – Three Months Ended June 30, 2019 and 2018

For the three months ended June 30, 2019, we did not record any revenues.  We spent $81,575 on general and administrative expenses.  We had interest expenses of $7,212.  As a result, we had a net loss of $88,787 for the three months ended June 30, 2019.

9

For the three months ended June 30, 2018, we did not record any revenues.  We spent 7,694 on general and administrative expenses.  We spent $374 on interest expenses.  As a result, we had a net loss of $8,068 for the three months ended June 30, 2018.

The $80,719, or 908.7% increase in net loss for the three months ended June 30 2019 compared to the three months ended June 30, 2018 is primarily due to the increase in general and administrative expenses during the three months ended June 30, 2019.  Our expenses during this period were primarily expenses involved in general operating expenses and expenses involved in developing the Telemedicine business.

Results of Operations – Six Months Ended June 30, 2019 and 2018

For the six months ended June 30, 2019, we did not record any revenues.  We spent $153,934 on general and administrative expenses.  We had interest expenses of $13,626.  As a result, we had a net loss of $167,560 for the six months ended June 30, 2019.

For the six months ended June 30, 2018, we did not record any revenues.  We spent $13,259 on general and administrative expenses.  We had other income of $1,404 and spent $748 on interest expenses.  As a result, we had a net loss of $12,603 for the six months ended June 30, 2018.

The $154,957 or 752.1% increase in net loss for the six months ended June 30, 2019 compared to the three months ended June 30, 2018 is primarily due to the increase in general and administrative expenses during the six months ended June 30, 2019.  Our expenses during this period were primarily expenses involved in general operating expenses and expenses involved in developing the Telemedicine business.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

Not applicable for smaller reporting companies.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer who is also our Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Chief Executive Officer who is also our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange

10

Act of 1934 ("Exchange Act"). Based upon that evaluation, our Chief Executive Officer who is also our Chief Financial Officer has concluded that our disclosure controls and procedures were not effective as of June 30, 2019, based on the following deficiencies:

Weaknesses in Accounting and Finance Personnel: We have a small accounting staff and we do not have the robust employee resources and expertise needed to meet complex and intricate GAAP and SEC reporting requirements of a U.S. public company. Additionally, numerous adjustments and proposed adjustments have been noted by our auditors. This is deemed by management to be a material weakness in preparing financial statements.

We do not have written control procedures, and do not have sufficient staff to implement the related controls. Management had determined that this lack of written control procedures and the lack of the implantation of segregation of duties, represents a material weakness in our internal controls.

Internal control has as its core a basic tenant of segregation of duties. Due to our limited size and economic constraints, the Company is not able to segregate for control purposes various asset control and recording duties and functions to different employees. This lack of segregation of duties had been evaluated by management and has been deemed to be a material control deficiency.

We will work to correct these deficiencies once we have revenues sufficient enough to hire new personnel.

Changes in Internal Control over Financial Reporting

Our management has also evaluated our internal control over financial reporting, and there have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the date of our last evaluation.

The Company is not required by current SEC rules to include, and does not include, an auditor's attestation report. The Company's registered public accounting firm has not attested to Management's reports on the Company's internal control over financial reporting.

11

PART II - OTHER INFORMATION

Item 1.   Legal Proceedings

None

Item 1A.  Risk Factors  

Not applicable for smaller reporting companies

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.   Defaults Upon Senior Securities.

None

Item 4.   Mine Safety Disclosures

Not Applicable

Item 5.   Other Information

None 

Item 6.   Exhibits

Exhibit 31* - Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 32* - Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.SCH**   XBRL Taxonomy Extension Schema Document

101.CAL**   XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF**   XBRL Taxonomy Extension Definition Linkbase Document

101.LAB**   XBRL Taxonomy Extension Label Linkbase Document

101.PRE**   XBRL Taxonomy Extension Presentation Linkbase Document

*  Filed herewith

**XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

12

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: August 13, 2019

24/7 KID DOC, INC.

By:/s/Timothy B. Shannon 

Timothy B. Shannon

Chief Executive Officer

Chief Financial Officer

13

EX-31

302 CERTIFICATION

I, Timothy B. Shannon, certify that:

         1. I have reviewed this quarterly report on Form 10-Q of 24/7 Kid Doc, Inc.;

         2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

         3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

         4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

      a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

      b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

      c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report, our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

      d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

         5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

         a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

         b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: August 13, 2019

/s/Timothy B. Shannon

Timothy B. Shannon

Chief Executive Officer

Chief Financial Officer

EX-32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of 24/7 Kid Doc, Inc. (the "Company") on Form 10-Q for the three and six months ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy B. Shannon, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

            (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

            (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/Timothy B. Shannon

Timothy B. Shannon

Chief Executive Officer

Chief Financial Officer

August 13, 2019

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 13, 2019
Details
Registrant CIK	0001094032
Fiscal Year End	--12-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	000-27251
Entity Registrant Name	24/7 Kid Doc, Inc.
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	59-3564984
Entity Address, Address Line One	8269 Burgos Ct.
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32836
Entity Address, Address Description	Address of principal executive offices
City Area Code	828
Local Phone Number	244-5980
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,964,655
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2

XML

Balance Sheets (June 30, 2019 unaudited) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 49,658	$ 76,286
Cash in attorney trust accounts	0	11,834
Total current assets	49,658	88,120
Property and equipment, at cost, net	759	902
Total Assets	50,417	89,022
Current liabilities:
Accrued expenses	8,000	17,500
Advance from shareholder	19,443	0
Notes payable	255,833	117,199
Total current liabilities	283,276	134,699
Stockholders' equity (deficit):
Preferred Stock, Value	100	100
Common Stock, Value	5,181	5,181
Additional paid-in capital	8,451,308	8,451,308
Treasury stock, 1,417,647 and 795,347 shares, at cost	(60,395)	(40,773)
Accumulated (deficit)	(8,629,053)	(8,461,493)
Total Stockholders' deficit	(232,859)	(45,677)
Total Liabilities and Stockholders' deficit	$ 50,417	$ 89,022

XML

Balance Sheets (June 30, 2019 unaudited) - Parenthetical - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	1,000,000	1,000,000
Preferred Stock, Shares Outstanding	1,000,000	1,000,000
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Shares, Issued	51,810,502	51,810,502
Common Stock, Shares, Outstanding	50,964,655	50,392,855
Treasury Stock, Shares	1,417,647	795,347

XML

Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Sales	$ 0	$ 0	$ 0	$ 0
Cost of sales and services	0	0	0	0
Gross profit	0	0	0	0
General and administrative expenses	81,575	7,694	153,934	13,259
Income (loss) from operations	(81,575)	(7,694)	(153,934)	(13,259)
Other income (expense):
Other income	0	0	0	1,404
Interest expense	(7,212)	(374)	(13,626)	(748)
Total other income (expense), net	(7,212)	(374)	(13,626)	656
Net income (loss)»	$ (88,787)	$ (8,068)	$ (167,560)	$ (12,603)
Per share information:
Basic and diluted income (loss) per share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Preferred Stock
Per share information:
Weighted average shares outstanding	1,000,000	0	1,000,000	0
Common Stock
Per share information:
Weighted average shares outstanding	50,455,513	50,810,502	50,668,979	50,810,502

XML

Statement of Stockholders' Equity (Deficit) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Total
Equity Balance, Starting at Dec. 31, 2017	$ 0	$ 5,181	$ 8,332,805	$ (39,009)	$ (8,400,130)	$ (101,253)
Shares Outstanding, Starting at Dec. 31, 2017	0	51,810,502		671,650
Subscribed stock			5,000			5,000
Net Income (Loss)	$ 0	$ 0	0	$ 0	(12,603)	(12,603)
Shares Outstanding, Ending at Jun. 30, 2018	0	51,810,502		671,650
Equity Balance, Ending at Jun. 30, 2018	$ 0	$ 5,181	8,337,805	$ (39,009)	(8,412,733)	(108,656)
Equity Balance, Starting at Dec. 31, 2018	$ 100	$ 5,181	8,451,308	$ (40,773)	(8,461,493)	(45,677)
Shares Outstanding, Starting at Dec. 31, 2018	1,000,000	51,810,502		795,347
Treasury stock purchased				$ (19,622)		(19,622)
Treasury stock purchased				622,300
Net Income (Loss)	$ 0	$ 0	0	$ 0	(167,560)	(167,560)
Shares Outstanding, Ending at Jun. 30, 2019	1,000,000	51,810,502		1,417,647
Equity Balance, Ending at Jun. 30, 2019	$ 100	$ 5,181	$ 8,451,308	$ (60,395)	$ (8,629,053)	$ (232,859)

XML

Statements of Cash Flows (unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net income (loss)	$ (167,560)	$ (12,604)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	143	144
Interest added to shareholder loans	0	748
Interest added to notes payable	13,626	0
Change in assets and liabilities:
Decrease in cash in attorney's trust account	11,834	0
Decrease in accounts payable and accrued expenses	(9,500)	0
Total adjustments	16,103	892
Net cash (used in) operating activities	(151,457)	(11,712)
Cash provided by financing activities:
Proceeds from notes payable	125,008	0
Proceeds from shareholder advance	19,443	0
Proceeds from subscribed shares	0	5,000
Purchase of treasury stock	(19,622)	0
Net Cash Provided by (Used in) Financing Activities	124,829	5,000
Increase (decrease) in cash and cash equivalents	(26,628)	(6,712)
Cash and Cash Equivalents, at Carrying Value, Beginning Balance	76,286	10,139
Cash and Cash Equivalents, at Carrying Value, Ending Balance	49,658	3,427
Supplemental cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	$ 0	$ 0

XML

(1) Basis of Presentation and Going Concern

6 Months Ended

Jun. 30, 2019

Notes

(1) Basis of Presentation and Going Concern

(1)Basis of Presentation and Going Concern 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and Rule 8.03 of Regulation SX.   As such, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (including normal, recurring adjustments) considered necessary for a fair presentation have been included.

The business plan is to create a company that will deliver pediatric services to children and adults 24 hours a day, 7 days a week here in the United States.  In addition, we will be looking to provide these same services via the Internet to people throughout the world, especially in places where it is difficult to have available pediatric doctors or the standard of care is a concern.  While we do not anticipate having significant cash outlays until we implement our business plan, there can be no assurance that such model will result in profitable operations, and/or that we will be able to obtain the debt or equity financing necessary to pay our expenses.  Either of these factors could result in us having difficulty continuing as a going concern.    The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities should we be unable to continue as a going concern.  

The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year.  For further information, refer to the financial statements of the Company as of and for the years ended December 31, 2018 and 2017, including notes, filed with the Company’s Form 10-12G.

XML

(2) Recent Accounting Pronouncements

6 Months Ended

Jun. 30, 2019

Notes

(2) Recent Accounting Pronouncements

(2)Recent Accounting Pronouncements 

The Financial Accounting Standards Board issued a new accounting standard on accounting for leases which went into effect at the end of 2018.  We have not entered into any lease arrangements and therefore this new accounting standard has no effect on our financial statements.

There are no other new accounting pronouncements for which adoption is expected to have a material effect on our financial statements in future accounting periods.

XML

(3) Basic and Diluted Income (Loss) Per Share

6 Months Ended

Jun. 30, 2019

Notes

(3) Basic and Diluted Income (Loss) Per Share

(3)Basic and Diluted Income (Loss) Per Share 

The Company calculates basic and diluted income (loss) per share as required by the FASB Accounting Standards Codification. Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods when we report a net loss, anti-dilutive common stock equivalents are not considered in the computation.  We did not have any dilutive common stock equivalents during any of the six-month periods ended June 30, 2019 and 2018.

XML

(3) Basic and Diluted Income (Loss) Per Share (Details) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Details
Dilutive Securities, Effect on Basic Earnings Per Share	$ 0	$ 0